184 related articles for article (PubMed ID: 8087520)
1. Toxicity of combined radiation and chemotherapy in non-small cell lung cancer.
Van Houtte P; Danhier S; Mornex F
Lung Cancer; 1994 Mar; 10 Suppl 1():S271-80. PubMed ID: 8087520
[TBL] [Abstract][Full Text] [Related]
2. [Non small-cell bronchial cancers: toxicity of the association radiotherapy-chemotherapy. Review of the literature].
Mornex F; Danhier S; Van Houtte P
Bull Cancer; 1994 Jan; 81(1):5-13. PubMed ID: 7949585
[TBL] [Abstract][Full Text] [Related]
3. Combined radiation and chemotherapy for unresectable non-small cell lung carcinoma.
Bleehen NM; Ball D; Belani CP; Bishop J; Douillard JY; Cox JD; Johnson DH; Le Chevalier T; Saunders MI; Shaw E
Lung Cancer; 1994 Mar; 10 Suppl 1():S19-23. PubMed ID: 8087510
[No Abstract] [Full Text] [Related]
4. Treatment-related acute esophagitis for patients with locoregionally advanced non-small cell lung cancer treated with involved-field radiotherapy and concurrent chemotherapy.
Bar-Ad V; Leiby B; Witek M; Xiao Y; Cui Y; Dai Y; Cao J; Axelrod R; Campling B; Both S; Werner-Wasik M
Am J Clin Oncol; 2014 Oct; 37(5):433-7. PubMed ID: 23388558
[TBL] [Abstract][Full Text] [Related]
5. Reduction of treatment breaks and radiation-induced esophagitis and pneumonitis using amifostine in unresectable non-small cell lung cancer patients receiving definitive concurrent chemotherapy and radiation therapy: a prospective community-based clinical trial.
Wynn RB; Mehta V
Semin Oncol; 2005 Apr; 32(2 Suppl 3):S99-104. PubMed ID: 16015543
[TBL] [Abstract][Full Text] [Related]
6. Five-year results of a phase II trial of hyperfractionated radiotherapy and concurrent daily cisplatin chemotherapy for stage III non-small-cell lung cancer.
Keene KS; Harman EM; Knauf DG; McCarley D; Zlotecki RA
Am J Clin Oncol; 2005 Jun; 28(3):217-22. PubMed ID: 15923791
[TBL] [Abstract][Full Text] [Related]
7. [Complications of radiotherapy for non-small cell lung cancer and their influence on the results of combined therapy].
Ragulin IuA
Vopr Onkol; 2012; 58(3):303-11. PubMed ID: 22888643
[No Abstract] [Full Text] [Related]
8. [Neoadjuvant treatment for early stages of non-small-cell lung carcinoma (NSCLC)].
Moro D
Rev Pneumol Clin; 2001 Nov; 57(5 Pt 2):S22-4. PubMed ID: 11924237
[No Abstract] [Full Text] [Related]
9. Response, toxicity, failure patterns, and survival in five Radiation Therapy Oncology Group (RTOG) trials of sequential and/or concurrent chemotherapy and radiotherapy for locally advanced non-small-cell carcinoma of the lung.
Byhardt RW; Scott C; Sause WT; Emami B; Komaki R; Fisher B; Lee JS; Lawton C
Int J Radiat Oncol Biol Phys; 1998 Oct; 42(3):469-78. PubMed ID: 9806503
[TBL] [Abstract][Full Text] [Related]
10. Influence of interfraction interval on the efficacy and toxicity of hyperfractionated radiotherapy in combination with concurrent daily chemotherapy in stage III non-small-cell lung cancer.
Shibamoto Y; Jeremic B; Acimovic L; Milicic B; Nikolic N
Int J Radiat Oncol Biol Phys; 2001 Jun; 50(2):295-300. PubMed ID: 11380214
[TBL] [Abstract][Full Text] [Related]
11. A phase III study of accelerated radiotherapy with and without carboplatin in nonsmall cell lung cancer: an interim toxicity analysis of the first 100 patients.
Ball D; Bishop J; Smith J; Crennan E; O'Brien P; Davis S; Ryan G; Joseph D; Walker Q
Int J Radiat Oncol Biol Phys; 1995 Jan; 31(2):267-72. PubMed ID: 7836079
[TBL] [Abstract][Full Text] [Related]
12. Effect of amifostine on toxicities associated with sequential chemotherapy and radiation therapy for unresectable non-small-cell lung cancer: results of a phase II trial.
Tannehill SP; Mehta MP; Larson M; Storer B; Pellet J; Kinsella TJ; Schiller JH
J Clin Oncol; 1997 Aug; 15(8):2850-7. PubMed ID: 9256128
[TBL] [Abstract][Full Text] [Related]
13. Clinical and dosimetric risk factors of acute esophagitis in patients treated with 3-dimensional conformal radiotherapy for non-small-cell lung cancer.
Zhang ZC; Xu J; Li BS; Zhou T; Lu J; Wang ZT; Li HS; Sun HF; Zhu J; Yu JM
Am J Clin Oncol; 2010 Jun; 33(3):271-5. PubMed ID: 19823071
[TBL] [Abstract][Full Text] [Related]
14. Acute esophagitis and late lung toxicity in concurrent chemoradiotherapy trials in patients with locally advanced non-small-cell lung cancer: analysis of the radiation therapy oncology group (RTOG) database.
Werner-Wasik M; Paulus R; Curran WJ; Byhardt R
Clin Lung Cancer; 2011 Jul; 12(4):245-51. PubMed ID: 21726824
[TBL] [Abstract][Full Text] [Related]
15. Oesophageal toxicity and hypofractionated concurrent chemoradiotherapy for non-small cell lung cancer.
Tho LM; Mahmood R; Leitch M; Brisbane I; Kakumanu S; Mohammed N
Clin Oncol (R Coll Radiol); 2009 Feb; 21(1):74. PubMed ID: 18986800
[No Abstract] [Full Text] [Related]
16. Predictors of radiation-induced esophageal toxicity in patients with non-small-cell lung cancer treated with three-dimensional conformal radiotherapy.
Singh AK; Lockett MA; Bradley JD
Int J Radiat Oncol Biol Phys; 2003 Feb; 55(2):337-41. PubMed ID: 12527046
[TBL] [Abstract][Full Text] [Related]
17. [Adjuvant treatment for early stages of non-small-cell lung carcinoma (NSCLC)].
Papadakis E
Rev Pneumol Clin; 2001 Nov; 57(5 Pt 2):S25-8. PubMed ID: 11924238
[No Abstract] [Full Text] [Related]
18. Cardiac toxicity in association with chemotherapy and radiation therapy in a large cohort of older patients with non-small-cell lung cancer.
Hardy D; Liu CC; Cormier JN; Xia R; Du XL
Ann Oncol; 2010 Sep; 21(9):1825-1833. PubMed ID: 20211871
[TBL] [Abstract][Full Text] [Related]
19. Toxicity of high-dose radiotherapy combined with daily cisplatin in non-small cell lung cancer: results of the EORTC 08912 phase I/II study. European Organization for Research and Treatment of Cancer.
Uitterhoeve AL; Belderbos JS; Koolen MG; van der Vaart PJ; Rodrigus PT; Benraadt J; Koning CC; González González D; Bartelink H
Eur J Cancer; 2000 Mar; 36(5):592-600. PubMed ID: 10738123
[TBL] [Abstract][Full Text] [Related]
20. Dosimetric correlations of acute esophagitis in lung cancer patients treated with radiotherapy.
Takeda K; Nemoto K; Saito H; Ogawa Y; Takai Y; Yamada S
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):626-9. PubMed ID: 15936536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
